Shots: Pelmeg (Pegfilgrastim, Biosimilar) is indicated to reduce the duration of neutropenia and the incidence of febrile neutropenia in patients treated with cytotoxic CT for malignancy CHMP recommends Pelmeg based […]readmore
Tags : Pelmeg
Shots: Mundipharma acquires all shares of the parent company of Cinfa, Infarco including Pelmeg (pegfilgrastim, biosimilar) having global market value $4.5B The acquisition focuses on expansion of biosimilar platform by […]readmore